Oct 9 (Reuters) - Humana's shares rose 15% in premarket trading on Friday after analysts said the health insurer is the ...
A Healthcare Dive analysis of highly anticipated stars data for next year shows a potpourri of winners and losers, though — ...
The trigger for Humana's surge was one contract plus the picture that contract is part of. Its largest plan, H5216, which ...
SpaceX — Shares were higher by 4% after Grain Management announced it reached an agreement with SpaceX to sell its nationwide ...
Humana Inc. stocks have been trading up by 12.24 percent following upbeat sentiment around its Medicare Advantage growth ...
The US Centers for Medicare & Medicaid Services said on Thursday that about 71% of Medicare Advantage prescription drug ...
Louisville Metro Council candidates answer questions about data centers, city spending and others topics in our 2026 voter ...
Baird analyst Michael Ha upgraded Humana (NYSE: HUM) from Neutral to Outperform with a price target of $596.00 (from $390.00).The analyst comments: We upgrade HUM to Outperform and raise our ...
Money Talks News on MSN
Your Medicare Advantage plan won't be back in 2027? A CPA on the Medigap window that protects you
A non-renewal letter feels like bad news. It also opens a rare Medigap window — if you act in time.
Options for Medicare Advantage plans are shrinking again in New Hampshire, with two major providers — CVS Health and BMC, ...
InvestorsHub on MSN
Humana says 95% of Medicare Advantage members are enrolled in plans rated four stars or higher for 2027
Humana (NYSE:HUM) reported that 95% of its Medicare Advantage members are enrolled in plans receiving quality ratings of at least four stars from the Centers for Medicare & Medicaid Services (CMS) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results